Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 7, 2007

Multibillion-Dollar Depression Market Gets Crowded

  • With the expiration of Teva Pharmaceuticals’ 180-day market exclusivity on its generic version of Pfizer’s blockbuster depression drug, four companies are ready to enter this multibillion-dollar market.

    Zoloft, indicated for depression and certain types of anxiety disorders, had U.S. sales of approximately $2.9 billion for the 12-month period ending Dec. 31, 2006, according to IMS Health. In 2005, Pfizer’s last full year on the market, sales reached $3.5 billion.

    Mylan Pharmaceuticals, Pliva, Actavis Group, and Lupin Pharmaceuticals each received approval for sertraline hydrochloride tablets, 25 mg, 50 mg, and 100 mg.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »